Consistently, in a more recent meta-analysis of 40 randomized controlled trials performed in patients with T2DM, compared with standard diabetes therapies (i.e., metformin, sulfonylureas, insulin, DPP-4i, thiazolidinediones) and placebo, GLP-1RA therapy was associated with significant reductions in inflammatory markers such as serum C-reactive protein (CRP) and TNF-, and a significant increase in adiponectin [80]
This is hugely important for our health as it plays a crucial role in the bodys defenses, in metabolising nutrients and in regulating various pathways essential for general equilibrium
Some are recovering from a specific injury
While microdosing, the semaglutide dose is 0.125 or 0.05 mg, which is far below the recommended therapeutic dose